Ginkgo Bioworks and XpresCheck Expand CDC’s Traveler-Based Genomic Surveillance Program to Detect Influenza Variants
Ginkgo Bioworks notes the program is an effective early warning system for viral variants, leveraging voluntary sampling from international travelers at major U.S. airports